...
首页> 外文期刊>Pediatric Nephrology >Mycophenolic acid inhibits oleic acid-induced mesangial cell activation through both cellular reactive oxygen species and inosine monophosphate dehydrogenase 2 pathways
【24h】

Mycophenolic acid inhibits oleic acid-induced mesangial cell activation through both cellular reactive oxygen species and inosine monophosphate dehydrogenase 2 pathways

机译:霉酚酸通过细胞活性氧和肌苷一磷酸脱氢酶2途径抑制油酸诱导的系膜细胞活化

获取原文
获取原文并翻译 | 示例
           

摘要

The synthesis of extracellular matrix (ECM) in mesangial cells (MCs) plays important roles in the development and progression of renal diseases, including chronic allograft nephropathy. Mycophenolic acid (MPA), an inhibitor of inosine monophosphate dehydrogenase 2 (IMPDH2), suppresses MC proliferation and ECM synthesis. However, the exact inhibitory mechanism of MPA on MCs has not been clearly elucidated. In this study we compared the inhibitory effects of MPA and IMPDH2 reduction [by using small interfering RNA (siRNA)] on oleic acid (OA)-induced fibronectin secretion and cellular reactive oxygen species (ROS) in mouse MCs. Growth-arrested MCs were stimulated with OA in the presence or absence of MPA, IMPDH2 siRNA, N-acetylcysteine (NAC), transforming growth factor beta (TGF-β) antibody or exogenous guanosine. Fibronectin secretion into the medium was examined by Western blot, dichlorodihydrofluorescein (DCF)-sensitive cellular ROS by fluorescence-activated cell scanning (FACS), TGF-β levels in the media by enzyme-linked immunosorbent assay (ELISA). OA increased fibronectin secretion, TGF-β and cellular ROS levels. A TGF-β neutralizing antibody effectively suppressed OA-induced fibronectin secretion. NAC and MPA completely suppressed OA-induced fibronectin secretion and decreased the levels of TGF-β and cellular ROS. However, IMPDH2 siRNA partly inhibited OA-induced MC activation. Exogenous guanosine successfully reversed the inhibitory effects of IMPDH2 siRNA on OA-induced MC activation. Pleiotropic inhibitory effect of MPA on OA-induced mouse MC activation was mediated via its antioxidant effect on cellular ROS production and partly via inhibition of IMPDH2 itself. Our results implicate ROS as an alternative therapeutic target for the prevention of hyperlipidemia-related glomerulopathy, chronic allograft nephropathy, and subsequent graft loss.
机译:肾小球膜细胞(MCs)中细胞外基质(ECM)的合成在包括慢性同种异体肾病在内的肾脏疾病的发生和发展中起着重要作用。麦考酚酸(MPA)是肌苷单磷酸脱氢酶2(IMPDH2)的抑制剂,可抑制MC增殖和ECM合成。但是,尚未明确阐明MPA对MC的确切抑制机制。在这项研究中,我们比较了MPA和IMPDH2减少的抑制作用(通过使用小干扰RNA(siRNA))对小鼠MC中油酸(OA)诱导的纤连蛋白分泌和细胞活性氧(ROS)的抑制作用。在存在或不存在MPA,IMPDH2 siRNA,N-乙酰半胱氨酸(NAC),转化生长因子β(TGF-β)抗体或外源鸟苷的情况下,用OA刺激生长停滞的MC。通过蛋白质印迹法检查纤维连接蛋白分泌到培养基中,通过荧光激活细胞扫描(FACS)检查二氯二氢荧光素(DCF)敏感的细胞ROS,通过酶联免疫吸附测定(ELISA)检查培养基中的TGF-β水平。 OA增加纤连蛋白的分泌,TGF-β和细胞ROS水平。 TGF-β中和抗体可有效抑制OA诱导的纤连蛋白分泌。 NAC和MPA完全抑制OA诱导的纤连蛋白分泌,并降低TGF-β和细胞ROS的水平。但是,IMPDH2 siRNA部分抑制了OA诱导的MC激活。外源鸟苷成功逆转了IMPDH2 siRNA对OA诱导的MC激活的抑制作用。 MPA对OA诱导的小鼠MC活化的多效抑制作用是通过其对细胞ROS产生的抗氧化作用介导的,部分是通过抑制IMPDH2本身介导的。我们的结果表明,ROS可作为预防高脂血症相关肾小球病,慢性同种异体肾病和随后的移植物丢失的替代治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号